C
ohn's disease (CD) is a multifactorial disease of the human digestive tract with a still unclear etiology. A genome-wide association study recently highlighted more than 30 distinct loci involved in CD pathogenesis. 1 Most of the human genes encountered in these human genomic loci were components of the autophagy pathway and innate immune system. 1 However, host genetic predisposition does not alone explain CD triggers, remission, and relapse. Environmental factors such as smoking, 2,3 appendectomy, 4 or endogenous microbiota are also involved in the onset of the disease. During the last decade, evidence implicating the host microbiota in CD has accumulated and it is now well established that changes in the gut microbiota are an important environmental component of inflammatory bowel diseases (IBDs). 5 Recent studies using rodent models have pinpointed the intricate dialog established between the host and the gut microbiota to maintain a mutual environment within the gut. For instance, Bouskra et al 6 demonstrated that the lymphoid tissue maturation and proliferation was driven by commensal gut bacteria through the NOD1 innate receptor. Additionally, the detection of enteric bacteria by Paneth cells through a MyD88-mediated activation protected host tissue against invasion by pathogenic and commensal bacteria. 7 Finally, Garrett et al 8 reported the existence of a communicable colitogenic microbiota shaped by T-bet cell deficiency in mice which was able to reinduce colitis in a genetically intact host. Taken together, these results indicate that the gastrointestinal tract is a strikingly complex ecosystem and its homeostasis requires finely balanced regulation and crosstalk between host cells and the resident microbiota. In humans, the gut microbiota is composed of trillions of microorganisms exceeding by a factor of 10 the total number of host cells, 9 with several thousands of different species detected. 10 A number of strategies have been used to examine the role of the intestinal microbiota in CD initiation and/ or maintenance. First of all, the search for persistent pathogenic agents led to the detection of both Mycobacterium avium paratuberculosis (MAP) 11 and the Escherichia coli
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AIEC pathovar 12 as potential infectious agents. However, these microorganisms are not always detected in CD patients, 5 suggesting other microbes might also play a role in CD. The non a priori approach of studying the gastrointestinal (GI) tract microbiota using DNA sequencing techniques has enabled the recovery of microbial diversity without the need for bacterial cultivation 13, 14 and has provided some new links between gut microbiota composition and IBD. 15 Dysbiosis, defined as an imbalance of the gut microbial community, 16 has since been characterized by an alteration in the balance between the Bacteroidetes and Firmicutes phyla. 15, 17 More precisely, the microbiota of CD patients is characterized by a decreased diversity within the Clostridium leptum group, with one species, Faecalibacterium prausnitzii, described as antiinflammatory. 18 In addition, increased numbers of the Proteobacteria and Actinobacteria phyla have also been observed in these molecular inventories. 10 However, there is a need to develop a finer resolution characterization of the gut microbiota in CD patients for a more precise measurement of health and disease.
The aim of this study was to provide new insights into CD-associated dysbiosis by combining molecular approaches through a ''global strategy.'' First, a bioinformatics approach was developed and applied to investigate, without a priori, the existing microbial 16S rRNA gene (rrs) molecular inventories produced from earlier case-control studies of CD. The in silico predictions were then validated using real time quantitative polymerase chain reaction (RT Q-PCR) to quantify these molecular species in fecal DNA samples from a well-characterized cohort of age-and sex-matched ileal CD patients and healthy volunteers. The RT Q-PCR results were further validated and augmented using a custom-designed phylogenetic microarray for intestinal bacteria.
MATERIALS AND METHODS

Subjects and Samples
With laboratory molecular studies used to perform the in silico predictions and validation steps, a total of 54 subjects were included (Table 1 ) comprising 24 CD and 30 healthy individuals. The 16 CD patients used as the CD control group (CCG) were part of a previously published double-blind controlled trial. 19 These patients suffered from ileal CD requiring surgery ileal or ileocecal resection. The healthy control group (HCG) was composed of 16 individuals selected for both age and sex ratio concordance with the CCG. Fecal samples were handled and DNA extracted as previously described. 17 All DNA samples were checked by agarose gel electrophoresis (1% w/v) stained with ethidium bromide, and also quantified using a Nanodrop ND-1000 spectrophotometer (Labtech, Palaiseau, France).
Sequence Datasets
A total of 3302 sequences recovered from four different rrs gene libraries produced by our group were analyzed, two of which were metagenomic and previously published. 15 The other two libraries were obtained by PCR amplification of rrs genes using DNA from the Elderly Subject Library (ESL) and the CD Patient Library II (CPLII) as templates. The sequence data produced from these two sources are publicly available (Supporting Table  1 ). We also included 45,076 rrs gene sequences recovered from nine libraries produced by other investigators studying IBD, and deposited with the NCBI database prior to November 2007.
rrs Gene Sequence Analysis and Phylogenetic (OTU) Specificity Searches
A two-stage strategy was used for the in silico analysis of the rrs gene sequences (Fig. 1) . First, the four libraries produced by our laboratory were analyzed to identify specific operational taxonomic units (OTUs) either associated with the ''CD'' or ''healthy'' datasets, or shared. Sequences were aligned using the MAFFT program 20 and distance matrices were computed with the DNADIST program. Chimeras and sequence anomalies were removed using the Mallard program. 21 An OTU was defined as sequences sharing at least 98% similarity. OTU detection and ecological estimates were determined using the DOTUR program. 22 OTUs were taxonomically assigned with Sequence Match application (RDP-II, release 9). The genetic diversity of CD patients and healthy subject libraries were compared using SONS program, enabling the inference of CD specificities. 23 A CD specificity was defined based on OTU sequences preferentially retrieved in either healthy or CD libraries or common to both. Then CD specificities were refined by measuring, by BLASTN analysis, their prevalence in nine 16S rDNA sequences libraries from external datasets (Supporting Table 1 ). The resulting selected OTU sequences were finally used for RT Q-PCR primers design using the PRISE program 24 (Table 2) . These OTUs were then searched for within the datasets downloaded from NCBI (Supporting Table 1 ). Conventional PCR and RT Q-PCR were then used to assess the detection rate of each candidate OTU among the 32 DNA samples (Table 1) . Those OTUs either not detected in the DNA samples or with no correlation with subject status were withdrawn as uninformative. On the basis of this analysis, six informative OTUs were identified.
Primer Specificity and PCR-based Assays
Primer specificities were assessed using ProbeCheck 25 and tested by RT Q-PCR on fosmid/plasmid from which the sequence originated, as well as cloned rrs gene amplicons produced from the cultured type strains. PCR was carried out using a PTC-100 thermocycler (MJ Research, Reno, NV) with HotStarTaq Master Mix (Qiagen, Courtaboeuf, France), following the conditions: 95 C FIGURE 1. 1) CD and healthy 16S rRNA gene libraries from our laboratory datasets were analyzed by a phylogenetic approach. OTUs sequences retrieved from healthy or CD libraries or common to both were selected. 2) CD specificities sequences were then compared to nine external 16S rRNA gene libraries and a second round of OTU selection was applied.
3) Candidate OTUs were validated on 16 CD and 16 healthy fecal DNA samples using PCR and RT PCR. 4) In parallel, in the same samples, a phylogenetic microarray approach was applied to validate CD specificities and analyze the microbial community structure of CD microbiota.
for 10 minutes and 25 cycles of amplification (95 C for 15 sec, 60 C for 1 min, 72 C for 30 sec) followed by a final elongation step at 72 C for 10 minutes. The RT Q-PCR was carried out as previously described 26 using an ABI Prism 7700 (Applied Biosystems, Courtaboeuf, France) using SYBR Green Master Mix (Applied Biosystems). The results for the RT Q-PCR primer specificity tests for uncultured Subdoligranulum sp. (OTUc03), Parabacteroides distasonis, (OTUh06), Ruminococcus bromii (OTUe10), Oscillibacter valericigenes (OTUa08), Bacteroides vulgatus (OTUa05), E. coli (OTUe11) are shown in Supporting Table 2 .
Bacterial Strains, Fosmids/Plasmids-bearing E. coli DH10B, Culture Conditions, and DNA Extraction
The anaerobic and aerobic bacterial strains used were: P. distasonis DSM20701T, Fusobacterium nucleatum DSM19508T, Fusobacterium naviforme DSM20699, Prevotella copri 18205T, Prevotella ruminicola ATCC19189T, O. valericigenes DSM18026T, Ruminococcus bromii 51896T, B. vulgatus ATCC8482, E. coli UEPSD S123 and DH10B. Detailed culture media and growth conditions are provided in the supplemental information data (Supporting Text).
Microarray
The 32 DNA samples were also used to prepare fluorescently labeled cRNA fragments of the rrs gene that were hybridized to a custom-designed phylogenetic microarray. A previous description and validation of the microarray are reported in Kang et al. 27 
Statistical Analysis
The chi-square test was used to test selected OTU independence toward CD status. All statistics were computed using R software and both ade4 28 and MADE4 29 packages. A principal coordinate analysis (PCA) was performed on the full distance matrix to map the overall genetic diversity retrieved in the laboratory dataset and point out CD specificities. A strip chart plot was performed on RT Q-PCR data to map CD and healthy microbiotas according to CD specificities. Medians were computed for each group using OTU Cycle threshold (Ct) values, and Wilcoxon's test was applied to RT Q-PCR data to assess significant differences between CD and healthy groups. Similarity between microbiotas according to their microarray profiles was assessed by a correspondence analysis (CoA). A ''between-class'' analysis was applied on the whole CoA dataset. A heatplot map of the first coordinate between class analysis was projected to highlight discriminating probes between healthy versus CD groups.
RESULTS
CD Microbiota Imbalances Revealed
The in silico analyses identified a CD specificity, defined as an OTU preferentially retrieved in either healthy or CD libraries, or common to both. These OTUs are associated with uncultured Subdoligranulum sp. (OTUc03), P. distasonis (OTUh06), R. bromii (OTUe10), O. valericigenes (OTUa08), B. vulgatus (OTUa05), and E. coli (OTUe11; Supporting Table 2 ; Supporting Fig. 1) . Except for OTUc03, the OTU sequences were 99% similar to the 16S rrs gene sequence of the closest strain.
The OTUs found to be most depleted in CD patients (Fig. 2) by both in silico and the RT Q-PCR analyses belonged principally to the C. leptum group and to a lesser extent within the Bacteroidetes phylum. Although the ''unknown'' OTUc03 was detected in most of the fecal samples (68.75% and 100% of CD and HCG, respectively) the RT Q-PCR analyses showed bacteria assigned to this OTU were present in significantly greater abundance in HCG than in CCG patients (DCt ¼ 17.48; P < 0.001) (Fig. 2) . The R. bromii OTUe10 was also detected in most of the samples (75% of CCG and 100% of HCG samples) but RT Q-PCR suggested that these bacteria were more abundant in the HCG than CCG group (DCt ¼ 13,56; P < 0.001). However, the most striking difference was observed for O. valericigenes (OTUa08), which was detected in only 12.5% of the CCG patients but in almost all (93.75%) of the HCG patients. Additionally, its abundance was significantly higher in healthy than in CCG (DCt ¼ 17.33, P < 0.001) (Fig. 2) . Based on the in silico predictions and RT Q-PCR data, P. distasonis (OTUh06) was detected in all 32 samples, but the abundance of bacteria assigned to this OTU was significantly higher in the healthy than in the CCG (DCt ¼ 10.07; P < 0.05). The B. vulgatus OTU (a05) was detected in most of the fecal samples (81.25% of CCG and in 93.75% of HCG groups), but the RT Q-PCR suggested there were no significant differences in the abundance of these bacteria between the two groups (DCt ¼ 7.24, P > 0.05). Finally, the E. coli OTU (e11) was detected in all 32 samples and there were no significant differences between the two groups in terms of its abundance (DCt ¼ 5.32, P > 0.05).
Collectively, these results indicated that some commensal gut bacterial inhabitants of healthy microbiota were depleted from CD samples. Moreover, as previously shown, E. coli was found to be overrepresented in some CD microbiota.
More Individual Variability in Microbiota from Patients with Active CD than in Healthy Individuals
The RT Q-PCR analyses suggested that in addition to the differences outlined above, the CD patients showed a greater degree of variance in the abundance of these OTUs, compared to healthy individuals (Fig. 3) , suggestive of greater intraindividual variations among CD patients. The chi-square test of the RT Q-PCR median distributions validated the observed topology, and indicated that all selected OTUs were not independent of the clinical status of the individuals. According to both PCA axes 1 and 2, which accounted for 71.48% of the variance, the fecal microbiota in CD patients appeared more scattered than those in healthy subjects. Interestingly, two fecal samples from healthy subjects (H17 and H21) were dispersed and closer to the CD datasets, while the fecal samples from two CD (Fig. 2) .
FIGURE 4.
CoA was computed on the whole phylogenetic microarray dataset and both CoA axes 1 and 2 were plotted which corresponded to 60.85% of whole inertia. CD (black, n ¼ 14) and healthy (white, n ¼ 16) microbiota were mapped according to their phylogenetic profiles.
patients (CD12 and CD22) appeared most similar to the profiles obtained from healthy individuals. Such observations suggest that patients considered otherwise ''healthy'' or ''diseased'' might actually be developing a microbiota that is ''at risk'' or ''remedial'' for CD, respectively. Finally, based on the PCA axis 1, the sensibility and specificity for detecting CD status were 93.75% and 87.5%, respectively.
Microarrays Confirmed the Discrimination Between CD and Healthy Microbiota
The same 32 fecal samples were used to produce fluorescently labeled cRNA probes and hybridized to a phylogenetic microarray specific for gut bacteria. 27 Correspondence analysis of the microarray data showed a tightly clustering schema for the profiles produced from most of the samples from healthy microbiota when PCA axes 1 and 2, accounting for 60.85% of the variance, were considered (Fig. 4) . Conversely, the samples from most of the CD patients demonstrated a large distribution spectrum, which was in accordance with RT Q-PCR data. Similarly, it was noticeable that samples H17 and H21 from HCG were again closest to the CD samples and CD12 and CD22 samples were more closely associated with the healthy samples. Furthermore, the co-inertia analysis supported the costructure produced from both the RT Q-PCR and microarray datasets (data not shown). Taken together, the healthy individuals and the patients suffering from an ileal CD were strongly discriminated according to their GI tract microbiota composition. However, whatever the method used the dysbiosis was not absolute.
Further Insights into CD Dysbiosis as Revealed by Microarray Analysis
Although the in silico and RT Q-PCR data provided insight into the fluctuations and abundance of six bacterial OTUs in healthy and CD patients, the microarray analyses provided additional and new insights. The discriminating probes, set as 5-fold different from the median between HCG and CCG (Fig. 5) revealed that F. prausnitzii, R. bromii, Eubacterium rectale, Ruminococcus albus, Bifidobacterium bifidum, P. distasonis, and Alistipes putredinis were more abundant in healthy than in CD microbiota. Very consistently, the OTUs predicted by the in silico analysis (and validated by RT Q-PCR), such as R. bromii and P. distasonis (Fig. 2) , were also in greater abundance. Although O. valericigenes was overrepresented in the HCG it was not similarly identified by the microarray, probably due to the stringent threshold we set for microarray statistical analysis. F. prausnitzii was not shown as statistically discriminated by RT Q-PCR because the species diversity was larger than an OTU (data not shown), as confirmed by the five probes highlighted in the microarray. Nevertheless, F. prausnitzii was detected as a healthy specific species. Furthermore, several OTUs that were identified by in silico predictions, but not statistically supported by PCR data (data not shown) were confirmed by microarray as overrepresented in healthy microbiota such as B. bifidum.
Overrepresented Species in CD Microbiota
Both the RT Q-PCR and microarray analyses showed that E. coli was overrepresented in the CD samples. Furthermore, other members of the Proteobacteria phylum, including Proteus vulgaris and Enterobacter cowanii, were also present in greater abundance in CD patients. In relation to Gram-positive bacteria, Enterococcus faecium species appeared to be overrepresented in a subset of patients and some patients were found to have a greater abundance of Streptococcus spp.
DISCUSSION
This study confirms recent data but also provides new insights into the phylogenetic specificities of CD-associated microbiota by combining bioinformatics predictions with biological validation, via a combination of RT Q-PCR and microarray approaches.
First, combination of RT Q-PCR targeting six human gut commensal bacteria in healthy and diseased individuals provided a preliminary diagnostic tool with both relevant sensitivity (93.75%) and specificity (87.5%) for discriminating subjects according to their health status. Then, species shown in this study as being ''healthy specific'' were also part of the recently described human intestinal phylogenetic core. 30 These species were also identified by the in silico analysis of data arising from non-European studies, and this shows that the dominant and prevalent bacterial species associated with healthy microbiota are likely universal. As such, these species should be targeted to monitor ''normal'' human GI tract health. Among the healthy microbiota, O. valericigenes was shown to be a very good phylogenetic marker of clinical status in the cohort examined here. Recently, Bifidobacterium longum and ''Oscillospira sp.,'' a genus close to O. valericigenes, were shown to grow cooperatively; the exopolysaccharides produced by B. longum were associated with the increased abundance of ''Oscillospira sp.'' in the human GI tract. 31 Our study also confirmed that F. prausnitzii, recently shown to produce antiinflammatory factors, was present in lower abundance in CD. 18, 32 Furthermore another member of the C. leptum group, R. bromii, was reduced in subjects with inflammation.
The bacterial genomes for some members of this ''healthy microbial core'' are now being sequenced via the Human Microbiome Project (http://www.hmpdacc.org/) and the International Human Microbiome Consortium (http:// www.human-microbiome.org/), and this will certainly help to better understand their functional role in the human GI tract. Such information will be critical to augment our understanding of the roles of these bacteria in health and disease. Despite these advances, many of the ''core'' microbes, their interactions and processes, and their role in health (or disease initiation and progression) remain cryptic. For instance, ''healthy'' bacterial structural components such as pili, flagella, and fimbriae, as well as metabolites and other gene products that might interact with human immune receptors (e.g., Toll-like receptors, Nod-like receptors), require better characterization. Dysbiosis in CD is probably not due to a single species, and our present study demonstrates the importance of a non a priori method approach, since it provided new species linked to active CD. For instance, OTUc03, which seems of interest, represents a species far from any sequence in the database and should therefore be targeted by single-cell genomics.
Some of the healthy species were missing, but, conversely, other species were more prevalent in CD patients microbiota. E. coli, as previously demonstrated, was overrepresented in CD patients. 12 In addition, several species from the Proteobacteria phylum were linked to the CD status. Most of these species (Streptococcus spp., Enterococcus spp., Staphylococcus spp., Legionella spp., Vibrio spp., and Proteus spp.) are known to be facultative anaerobes, and it seems thus that the microbiota during active ileal CD is adapted to a high redox potential. The variability among CD patients appeared higher than among healthy individuals, as reported in the literature. 32 Such variability among CD patients might explain why OTUs specific to CD status have been difficult to detect. A hypothesis is that individuals who are predisposed to CD are less able to regulate the microbial makeup of their gut, leading to an unstable microbial population. Moreover, the CD microbial profiles highlighted by our data are consistent with the deleterious schema believed to be caused by changes in antimicrobial peptide production which result in the killing of B. vulgatus, E. coli, and E. faecalis.
33
This study focused on patients suffering from an active ileal form of CD, which is of particular interest FIGURE 5 . A between-class analysis was computed on the CoA results from the whole dataset. A heat plot map was applied on the discriminated probes retrieved from the first coordinate of the between-class analysis. Red indicates high intensity probes and corresponds to an overrepresentation of species in samples. Conversely, blue indicates an underrepresentation.
because of its proximity to the Peyer patches and immune cells. Because CD is a disease with different phenotypes in terms of pathology and progression, host genetics and lifestyle differences might explain the discrepancies between results arising from different cross-sectional studies. Several ongoing projects using high-throughput metagenomics approaches (such as the EU-funded project METAHIT, http://www.metahit.eu/) will allow deeper analyses that will provide additional confirmation of our in silico predictions. These metagenomic datasets from CD patients will help identify which bacterial genes are under-or overrepresented during inflammation. Clinically, dysbiosis can be studied further by a large screening of individuals by a fast quantification of the six OTUs we detected here as discriminatory of CD status.
